Venlafaxine-induced serotonin syndrome with relapse following amitriptyline.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 10727586.
- Also identified by PMC identifier 1741568.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A case of venlafaxine-induced serotonin syndrome is described with relapse following the introduction of amitriptyline, despite a 2-week period between the discontinuation of one drug and the commencement of the other. Electroencephalography may play an important part in diagnosis. With the increasing use of selective serotonin re-uptake inhibitors, greater awareness of the serotonin syndrome is necessary. Furthermore, the potential for drug interactions which may lead to the syndrome needs to be recognised.
Medical subject headings
- Adrenergic Uptake Inhibitors
- Amitriptyline
- Cyclohexanols
- Serotonin Syndrome
- Selective Serotonin Reuptake Inhibitors